Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance

Authors: Roof, Scott A., Jabalee, James, Rettig, Eleni M., Chennareddy, Susmita, Ferrandino, Rocco M., II, Chen, Sida, Posner, Marshall R., Genden, Eric M., Chai, Raymond L., Sims, John, Thrash, Elaine, Stern, Scott J., Kalman, Noah S., Yarlagadda, Sreenija, Raben, Adam, Clements, Lydia, Mendelsohn, Abie, Kaczmar, John M., Pandey, Yadav, Bhayani, Mihir, Del Vecchio Fitz, Catherine, Hanna, Glenn J.

Source: In Oral Oncology August 2024 155

Systematic review of neuroendocrine carcinomas of the oropharynx

Authors: Froehlich, Michael H., Shih, Michael C., Shehee, Lindsey, Kompelli, Anvesh R., Aylward, Alana, Nguyen, Shaun A., Kaczmar, John M., Nathan, Cherie Ann, Day, Terry, Neskey, David M.

Source: Head & neck. 44(7):1725-1736

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100153770284.0x000001&indx=1&recIds=ETOCvdc_100153770284.0x000001

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma.

Authors: Yoon, Angela J., Carvajal, Richard D., Graboyes, Evan M., Kaczmar, John M., Albergotti, William G., Kejner, Alexandra E., Troob, Scott H., Philipone, Elizabeth, Anoma, Jean-Sebastien, Armeson, Kent E., Hill, Elizabeth G., Richardson, Mary S., Woods, Tina R., Chera, Bhishamjit S., Nourollah-Zadeh, Farzad, Lee, Byung J., Pandruvada, Subramanya, Kourtidis, Antonis, Kingsley, Christina, O'Quinn, Elizabeth C.

Source: Frontiers in Immunology; 2025, p1-12, 12p

Subject Terms: TOLL-like receptor agonists, PATHOLOGIC complete response, SQUAMOUS cell carcinoma, ORAL cancer

Preventing Cisplatin-Induced Hearing Loss in Adults: A Systematic Review and Meta-Analysis.

Authors: Briggs, Erin E., Kallenberger, Ethan M., Nguyen, Shaun A., Dixon, Peter R., Drawdy, Allyson V., Kejner, Alexandra E., Kaczmar, John M., Newman, Jason G., Albergotti, W. Greer

Source: Otology & Neurotology; Apr2025, Vol. 46 Issue 4, p351-357, 7p

Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation

Authors: Yan, Flora, Li, Hong, de Almeida, John R., Kaczmar, John M., Pipkorn, Patrik, Zenga, Joseph, Richardson, Mary S., Neskey, David M., Sharma, Anand K., Day, Terry A.

Source: Otolaryngology and head and neck surgery. 165(4):536-549

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN627829952&indx=1&recIds=ETOCRN627829952

Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer

Authors: Yan, Flora, Li, Hong, Kaczmar, John M.

Source: JAMA otolaryngology-- head & neck surgery. 146(12):1109-1119

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN633589005&indx=1&recIds=ETOCRN633589005

Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival

Authors: Graboyes, Evan M., Ellis, Mark A., Li, Hong, Kaczmar, John M., Sharma, Anand K., Lentsch, Eric J., Day, Terry A., Hughes Halbert, Chanita

Source: Cancer. 124(15):3181-3191

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100123829301.0x000001&indx=1&recIds=ETOCvdc_100123829301.0x000001

Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer

Authors: Ellis, Mark A., Graboyes, Evan M., Wahlquist, Amy E., Neskey, David M., Kaczmar, John M., Schopper, Heather K., Sharma, Anand K., Morgan, Patrick F., Nguyen, Shaun A., Day, Terry A.

Source: Otolaryngology and head and neck surgery. 158(4):649-659

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN615536384&indx=1&recIds=ETOCRN615536384

A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced ccRCC.

Authors: Kim, Miso, McDermott, Raymond S., Williamson, Stephen K., Cho, Byoung Chul, Dowlati, Afshin, Lakhani, Nehal J., Malhotra, Jyoti, Kaczmar, John M., Papadopoulos, Kyriakos P., Safran, Howard, Aljumaily, Raid, Mani, Jayakumar, Fang, Fang, Chen, Shuquan, Salvati, Mark, Lowy, Israel, Fury, Matthew G., Lewis, Karl

Source: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p434-434, 140p

The Inconsistent Assessment of Quality of Life in Patients Treated for Head and Neck Cancer with Anti-EGFR Inhibitors: A Systematic Scoping Review.

Authors: Sutton, Sarah R., Taniguchi, April N., Nguyen, Shaun A., Albergotti, William G., Kaczmar, John M., Kejner, Alexandra E., Newman, Jason G.

Source: Cancers; May2023, Vol. 15 Issue 9, p2475, 14p

Subject Terms: ONLINE information services, CINAHL database, EPIDERMAL growth factor, SYSTEMATIC reviews, HEAD & neck cancer, PATIENT-centered care, EARLY detection of cancer, TREATMENT effectiveness, RISK assessment, QUALITY of life, MEDLINE, CHEMICAL inhibitors

Anatomic Region of Cutaneous Melanoma Impacts Survival and Clinical Outcomes: A Population-Based Analysis.

Authors: Shannon, Christian M., Mehta, Neil K., Li, Hong, Nguyen, Shaun A., Koochakzadeh, Sina, Elston, Dirk M., Kaczmar, John M., Day, Terry A.

Source: Cancers; Feb2023, Vol. 15 Issue 4, p1229, 13p

Subject Terms: MELANOMA prognosis, MORTALITY risk factors, CONFIDENCE intervals, CROSS-sectional method, HEAD & neck cancer, SKIN tumors, LEG, RISK assessment, SEX distribution, SURVIVAL analysis (Biometry), DESCRIPTIVE statistics

Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma.

Authors: Hamid, Omid, Wang, Ding, Kim, Tae Min, Kim, Sang-We, Lakhani, Nehal J., Johnson, Melissa Lynne, Groisberg, Roman, Papadopoulos, Kyriakos P., Kaczmar, John M., Middleton, Mark R., Spira, Alexander I., Williamson, Stephen K., Rabinowits, Guilherme, Gutierrez, Rodolfo, McKean, Meredith, Chen, Shuquan, Cassidy, James, Mani, Jayakumar, Sims, Tasha Nicholle, Kroog, Glenn

Source: Journal of clinical oncology. 39(15 suppl):9515-9515

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173223306.0x000001&indx=1&recIds=ETOCvdc_100173223306.0x000001

Randomized phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, advanced head and neck squamous cell carcinoma (HNSCC).

Authors: Bauman, Julie E., Saba, Nabil F., Roe, Denise, Bauman, Jessica R., Kaczmar, John M., Bhatia, Aarti K., Muzaffar, Jameel, Julian, Ricklie Ann, Wang, Steven, Bearelly, Shethal, Baker, Audrey, Steuer, Conor Ernst, Giri, Anshu, Burtness, Barbara, Centuori, Sara, Caulin, Carlos, Saboda, Kathylynn, Obara, Stefanie, Chung, Christine H.

Source: Journal of clinical oncology. 39(15 suppl):6015-6015

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173208617.0x000001&indx=1&recIds=ETOCvdc_100173208617.0x000001

Association of pathological response to neoadjuvant pembrolizumab with tumor PD-L1 expression and high disease-free survival (DFS) in patients with resectable, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC).

Authors: Wise-Draper, Trisha Michel, Takiar, Vinita, Mierzwa, Michelle Lynn, Casper, Keith, Palackdharry, Sarah, Worden, Francis P., Old, Matthew O., Dunlap, Neal E., Kaczmar, John M., Patil, Yash, Riaz, Muhammad Kashif Kashif, Hamilton, Aubrey, Gillenwater, Ann M., Hinrichs, Benjamin H, Bell, Diana, Allen, Casey, Lanverman, Sheena M, Zhang, Li, Lee, J. Jack, Gillison, Maura L.

Source: Journal of clinical oncology. 39(15 suppl):6006-6006

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173208519.0x000001&indx=1&recIds=ETOCvdc_100173208519.0x000001

Immune Checkpoint Inhibitors for Advanced Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis.

Authors: Mehta, Neil K., Li, Andraia R., Nguyen, Shaun A., Kaczmar, John M., Neskey, David M., Day, Terry A.

Source: Targeted Oncology; Nov2021, Vol. 16 Issue 6, p743-752, 10p

Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.

Authors: Graboyes, Evan M., Sterba, Katherine R., Hong Li, Warren, Graham W., Alberg, Anthony J., Calhoun, Elizabeth A., Nussenbaum, Brian, McCay, Jessica, Marsh, Courtney H., Nosayaba Osazuwa-Peters, Neskey, David M., Kaczmar, John M., Sharma, Anand K., Harper, Jennifer, Day, Terry A., Hughes-Halbert, Chanita

Source: JCO Oncology Practice; Oct2021, Vol. 17 Issue 10, p632-e1523, 13p

Subject Terms: HEAD tumors, PATIENT aftercare, PILOT projects, EVALUATION of human services programs, HEALTH services accessibility, OPERATIVE surgery, RESEARCH methodology, ORGANIZATIONAL structure, BLACK people, PATIENT-centered care, MEDICAL care, INTERVIEWING, HUMAN services programs, MEDICAL protocols, CANCER patients, ORGANIZATIONAL change, POSTOPERATIVE period, RESEARCH funding, QUALITY assurance, MEDICAL referrals, DESCRIPTIVE statistics, SCALE analysis (Psychology), RADIOTHERAPY, PATIENT education, DATA analysis software, THEMATIC analysis, NECK tumors

Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis.

Authors: Donaldson, Lane B., Yan, Flora, Morgan, Patrick F., Kaczmar, John M., Fernandes, Jyotika K., Nguyen, Shaun A., Jester, Rachel L., Day, Terry A.

Source: Endocrine (1355008X); Apr2021, Vol. 72 Issue 1, p27-39, 13p

Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion--Related Reactions.

Authors: Sion, Amy M., Milburn, Lyndsey, Kaczmar, John M.

Source: JCO Oncology Practice; Jan2021, Vol. 17 Issue 1, p54-56, 4p

Subject Terms: MONOCLONAL antibodies

Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer.

Authors: Graboyes, Evan M., Halbert, Chanita Hughes, Hong Li, Warren, Graham W., Alberg, Anthony J., Calhoun, Elizabeth A., Nussenbaum, Brian, Marsh, Courtney H., McCay, Jessica, Day, Terry A., Kaczmar, John M., Sharma, Anand K., Neskey, David M., Sterba, Katherine R.

Source: JCO Oncology Practice; Dec2020, Vol. 16 Issue 12, p820-e1432, 17p

Subject Terms: BLACK people, CLINICAL competence, COMMUNICATION, COMMUNITIES, HEAD tumors, HEALTH care teams, HEALTH facilities, HEALTH services accessibility, HOSPITAL wards, INTERPERSONAL relations, INTERPROFESSIONAL relations, INTERVIEWING, MATHEMATICAL models, RESEARCH methodology, MEDICAL care, MEDICAL protocols, NECK tumors, ONCOLOGY, PHYSICIANS, POSTOPERATIVE period, RADIOTHERAPY, RESEARCH funding, SQUAMOUS cell carcinoma, TIME, TRAVEL, QUALITATIVE research, THEORY, JUDGMENT sampling, SOCIOECONOMIC factors, THEMATIC analysis, AT-risk people, DATA analysis software, DESCRIPTIVE statistics, TREATMENT delay (Medicine)

Geographic Terms: SOUTH Carolina

This result is not displayed to guests.
Login for full access.